# ROPIVACAINE HYDROCHLORIDE
> **ANDA206091** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2023-10-26
## Drug
- **FDA Application Number:** ANDA206091
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ROPIVACAINE HYDROCHLORIDE
- **Generic name:** ROPIVACAINE HYDROCHLORIDE
- **Active ingredients:** ROPIVACAINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** MYLAN LABS LTD
- **Manufacturer:** Mylan Institutional LLC
- **First approval:** 2023-10-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206091)
---
*AI Analytics · CC0 1.0*